| 25/03/2022 |
Oasmia Pharmaceutical AB |
Francois-Regis Martelet |
Chief Executive Officer (CEO)/Managing Directory |
|
Subscription |
Oasmia Pharmaceutical AB BTA |
BTA |
SE0017564958 |
22/03/2022 |
12,200 |
Quantity |
1.68 |
SEK |
|
Notification
|
| 24/03/2022 |
Oasmia Pharmaceutical AB |
Peter Zonabend |
Member of the Board of Directors |
|
Subscription |
Oasmia BTA |
BTA |
SE0017564958 |
22/03/2022 |
120,000 |
Quantity |
1.68 |
SEK |
|
Notification
|
| 20/12/2021 |
Oasmia Pharmaceutical AB |
Francois-Regis Martelet |
Chief Executive Officer (CEO)/Managing Directory |
|
Allotment |
Personaloption 2021/2024 |
Option |
|
19/12/2021 |
2,250,000 |
Quantity |
0.00 |
SEK |
|
Notification
|
| 20/12/2021 |
Oasmia Pharmaceutical AB |
Fredrik Järrsten |
Chief Financial Officer (CFO) |
|
Allotment |
Personaloption 2021/2024 |
Option |
|
19/12/2021 |
1,350,000 |
Quantity |
0.00 |
SEK |
|
Notification
|
| 19/08/2021 |
Oasmia Pharmaceutical AB |
Anders Härfstrand |
Chairman of the Board of Directors |
|
Acquisition |
Aktie |
Share |
SE0000722365 |
19/08/2021 |
20,000 |
Quantity |
2.656629 |
SEK |
|
Notification
|
| 16/07/2021 |
Oasmia Pharmaceutical AB |
Peter Zonabend |
Member of the Board of Directors |
|
Acquisition |
Oasmia Pharmaceutical AB |
Share |
SE0000722365 |
16/07/2021 |
100,000 |
Quantity |
3.026236 |
SEK |
|
Notification
|
| 14/07/2021 |
Oasmia Pharmaceutical AB |
Francois-Regis Martelet |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
Oasmia Pharmaceutical AB |
Share |
SE0000722365 |
13/07/2021 |
41,000 |
Quantity |
2.9602439 |
SEK |
|
Notification
|
| 14/07/2021 |
Oasmia Pharmaceutical AB |
Fredrik Järrsten |
Chief Financial Officer (CFO) |
Yes |
Acquisition |
Oasmia Pharmaceutical AB |
Share |
SE0000722365 |
14/07/2021 |
20,000 |
Quantity |
2.91 |
SEK |
|
Notification
|
| 09/07/2021 |
Oasmia Pharmaceutical AB |
Birgit Agneta Stattin Norinder |
Member of the Board of Directors |
|
Acquisition |
Oasmia Pharmaceutical AB |
Share |
SE0000722365 |
08/07/2021 |
35,000 |
Quantity |
2.985142857 |
SEK |
|
Notification
|
| 06/07/2021 |
Oasmia Pharmaceutical AB |
Anders Härfstrand |
Chairman of the Board of Directors |
|
Acquisition |
Aktie |
Share |
SE0000722365 |
06/07/2021 |
100,000 |
Quantity |
2.85653 |
SEK |
|
Notification
|